These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10201422)

  • 1. Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.
    Palomäki H; Kaste M; Berg A; Lönnqvist R; Lönnqvist J; Lehtihalmes M; Hares J
    J Neurol Neurosurg Psychiatry; 1999 Apr; 66(4):490-4. PubMed ID: 10201422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complaints of poststroke insomnia and its treatment with mianserin.
    Palomäki H; Berg A; Meririnne E; Kaste M; Lönnqvist R; Lehtihalmes M; Lönnqvist J
    Cerebrovasc Dis; 2003; 15(1-2):56-62. PubMed ID: 12499712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine.
    Honig A; Kuyper AM; Schene AH; van Melle JP; de Jonge P; Tulner DM; Schins A; Crijns HJ; Kuijpers PM; Vossen H; Lousberg R; Ormel J;
    Psychosom Med; 2007; 69(7):606-13. PubMed ID: 17846258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-stroke depression, not to be underestimated.
    Hachinski V
    Lancet; 1999 May; 353(9166):1728. PubMed ID: 10347982
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke.
    Niedermaier N; Bohrer E; Schulte K; Schlattmann P; Heuser I
    J Clin Psychiatry; 2004 Dec; 65(12):1619-23. PubMed ID: 15641866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Major depressive episodes in patients over 70 years of age. Evaluation of the efficiency and acceptability of tianeptine and mianserin].
    Brion S; Audrain S; de Bodinat C
    Presse Med; 1996 Mar; 25(9):461-8. PubMed ID: 8685201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled study with mianserin.
    Tanum L; Malt UF
    Scand J Gastroenterol; 1996 Apr; 31(4):318-25. PubMed ID: 8726297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant whole body acupuncture in depression. A placebo-controlled study with standardized mianserin therapy].
    Röschke J; Wolf C; Kögel P; Wagner P; Bech S
    Nervenarzt; 1998 Nov; 69(11):961-7. PubMed ID: 9859117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study.
    Lauritzen L; Bendsen BB; Vilmar T; Bendsen EB; Lunde M; Bech P
    Psychopharmacology (Berl); 1994 Feb; 114(1):119-22. PubMed ID: 7846193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poststroke depression: an 18-month follow-up.
    Berg A; Palomäki H; Lehtihalmes M; Lönnqvist J; Kaste M
    Stroke; 2003 Jan; 34(1):138-43. PubMed ID: 12511765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mianserin add-on, on the intensity of opioid withdrawal symptoms during detoxification program--a randomized, double blind, placebo controlled, prospective study.
    Herman I; Shamir D; Bar-Hamburger R; Pick CG; Schreiber S
    Addict Behav; 2005 Jul; 30(6):1154-67. PubMed ID: 15925125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
    J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
    Ferreri M; Lavergne F; Berlin I; Payan C; Puech AJ
    Acta Psychiatr Scand; 2001 Jan; 103(1):66-72. PubMed ID: 11202131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram.
    Andersen G; Vestergaard K; Lauritzen L
    Stroke; 1994 Jun; 25(6):1099-104. PubMed ID: 8202964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.